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The research trends on stent for blood arteries are reviewed by bibliometric analysis using 7,790 journal articles
published from 1986 to 2013 of the Web of Science database. The bibliometric indicators are applied to analyze the
journal article data, which are simple number of publications for selecting key players, citation indicators for
measuring qualitative research performance, collaboration indicators for figuring out the degree of international
collaboration and keyword mapping for identifying the research trends. The studies of stent for blood arteries are
investigated on the basis of the analysis by countries, institutions and topic changing. The leading countries and
institutions published many high-quality journal articles with strong international collaboration. In this report, the
current status and future of research trends are clearly revealed from the periodic topic changing analysis. The
keywords such as ‘drug eluting stent’, ‘stent coated with new polymers’ and ‘drug delivery systems’ have come into
the recent stent-related research, which means lots of efforts are under way to overcome the present limitations of
the research.
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A stent is a small mesh tube to be used to treat weak
and narrow arteries. Normal arteries are blood vessels
that are able to carry blood away from heart to other
parts of human body. However, problems occur some-
times in the arteries of old or sick people. In the case
of good chance, a stent is placed in an artery as part of
a procedure called percutaneous coronary intervention
(PCI). PCI restores blood flow through narrow or
blocked arteries of the body. A replaced stent helps
support the inner wall of the artery within a certain
period of time for few months or years after putting
on PCI.
Some stents are coated with polymeric drugs that are
slowly and continuously released into the artery. The
stents are called drug-eluting stents (DES). Introducing
DES, several problems have been reduced dramatically
in coronary artery stenting by limiting long-term
efficacy [1]. The medicine helps prevent the artery
from coming blocked again. Recently, researches have* Correspondence: yksung@dongguk.edu
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unless otherwise stated.indicated that the reduction in restenosis might have
been obtained at the expense of a higher incidence of
stent thrombosis, particularly late stent thrombosis [2].
In the present paper, recent progress has been re-
viewed on the stent coating for heart blood arteries of
human body. The research trends of the stent coating
for heart blood arteries are reviewed using 7,790 journal
articles published from 1986 to 2013 in various aspects.Review
The journal articles for analysis were collected using
search query made of keywords using Web of Science
(WoS) database provided by Thomson Scientific
(Philadelphia, PA, USA). The used search query
was shown in Table 1. The dataset contains Science
Citation Index (SCI) and SCI-Expanded (SCIE) with a
document type limited to the ‘article’ reflecting the ac-
curate R&D trends and the search period was set to
1986 ~ 2013. The basic analysis was carried out using
the COMPAS (COMPetitive Analysis System) deve-
loped by KISTI (Korea Institute of Science and Tech-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Search query for the analysis of research trends on stent for blood arteries
Search query Limitation
TS = (stent* and ((bio* near/3 stent*) or “biodegradable polymer*” or “biocompatible polymer*” or
“biocompatible material*” or “biomaterial*” or anti-coagulant* or “biomedical coating” or “biomedical
implant*” or “drug-eluting” or “drug elut*” or “drug delivery coating system”))
PY = 1986 ~ 2013 document type = ‘article’
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Search Technology, Inc. The VOSviewer of CWTS and
Netminer 4.0 provided by Cyram are used for the net-
work analysis.
Figure 1 shows the number of publications by the year
of 1986 ~ 2013. The annual number of journal articles
since 1986 increases steadily in spite of a little fluctuation
between 2000 and 2002. However, the accumulative num-
ber of publications gradually increases. We can estimate
the technology growth level by curve fitting to a suitable
model. In this case, the accumulative data are able to be
explained by a logistic model. In a logistic model, the gen-




where L is an upper limit of technology growth,
t means time and the coefficients α and β are the para-
meters which determine the shape of the growth curves.Figure 1 The number of publications on stent by year; The fitting curWe can estimate the year of inflection point to 2015.3
by the fitting curve as shown in the inset of Figure 1,
which means the current research on stent being in the
midst of active time.
In order to investigate the stent-related research trends
by the authors of countries, we have extracted county in-
formation from addresses of author-affiliation. The re-
searches on stents have been performed by 71 countries
from 1986 to 2013. Figure 2 shows a share of number of
publications of top-10 countries which take a share
about 74% of the total publications. USA ranks the first
with 2,586 papers and Germany (1,122), Italy (833),
China (575), Netherlands (547), South Korea (517), UK
(484), Japan (461), France (406), and Canada (352) are
come along after USA. The annual number of publica-
tions for the whole countries generally increases as
shown in Figure 3.
The research performance should be considered
quantitatively as well as qualitatively. If the simple
number of publications is used as a quantitative indica-
tor, the widely known indicator for research qualityves of accumulative number of publications (inset).
Figure 2 The share of publications on stent-related research.
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the quality-factor(Q-factor), which is defined as the
average number of citations per publication(CPP) of a
country compared to the world-wide average CPP in a
given research field [5]. It could be regarded that the
research level is over world average level when the Q-
factor is more than 1. The Netherlands shows 1.64 as
the highest Q-factor and Canada (1.45), UK (1.39),
France (1.31), USA (1.23), Italy (1.15) and Germany
(1.14) show the values over 1.Figure 3 Annual number of publications on stent by year of top-10 cThe collaboration network analysis between coun-
tries has been investigated. USA collaborates with 57
countries including Germany, Italy, the Netherlands,
Canada, France, UK, and South Korea on stent-related
research. Figure 4 shows the international collabo-
ration network of top-21 countries publishing more
than 100 papers. The width of lines means the strength
of collaboration and the size of nodes represents the
number of publications of the country. We can find
that research on stent has been performed and deve-
loped by building strong collaboration between USA
and other countries in Europe. Table 2 shows the sum-
mary of quantitative and qualitative indicator-values
for top-10 countries of the stent-related research.
Figure 5 shows the scatter chart to see the relation bet-
ween Q-factor and number of publications and the size
of circles refers the number of collaborations.
In a view of institution, about 5,000 institutions pub-
lished the stent-related journal articles. Table 3 shows
the status of top-20 institutions. Columbia University
in USA published 214 papers and Cardiovascular Re-
search Foundation (202), Harvard University (202),
Erasmus University Medical Center (199) and Washington
Hospital Center (153) published over 150 papers. Many
of institutes are collaborating with each other for a re-
search on stent. Thus, we have used the international
collaboration strength (ICS) indicator which is obtained
by ‘the share of foreign institutions collaborating with aountries.
Figure 4 Collaboration network map among top-21 countries.
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the Q-factor, the field-averaged ICS is defined as the L-
factor. As a same rule for the Q-factor, an institution is
said to be at the field average when its L-factor is equal
to unit [5]. Figure 6 shows the relationship of Q-L values
of the top-20 institutions. As shown in the Figure 6,
the plot is divided into four sections by the guide-line
(Q = 1 and L = 1). The institutions in the Section I have
high quality and high international network where al-
most the whole top-20 institutions are belonging. The
institutions in Section III (Seoul National University,
Yonsei University and Shanghai Jiao Tong University)Table 2 Quantitative and qualitative indicators for top-10
countries of the stent-related research
Countries No. of pub. CPP Q-factor No. of collab.
USA 2586 23.24 1.23 57
Germany 1122 21.67 1.14 48
Italy 833 21.88 1.15 43
China 575 7.03 0.37 25
Netherlands 547 31.02 1.64 41
South Korea 518 14.69 0.77 28
UK 484 26.26 1.39 41
Japan 461 12.22 0.64 31
France 406 24.88 1.31 44
Canada 352 27.50 1.45 33show low performance and relatively domestic network
though large publication outputs.
Meanwhile, the research trends can be understood in a
view of topic changing. The visualization technique by
the co-word mapping is widely used to identify know-
ledge structure in a certain research field. In the present
study, keywords given by authors are used with the
VOSviewer software, which suggests the combinationFigure 5 Q-factor vs. number of publications; the size of circles
refers the number of collaborations.
Table 3 The top-20 institutions in the field of stent research
Institution Country No. of pub. CPP Q L Section
Columbia Univ. USA 214 29.94 1.58 2.42 I
Cardiovasc Res Fdn. USA 202 27.58 1.45 2.34 I
Harvard Univ. USA 202 31.95 1.69 1.87 I
Erasmus MC Netherlands 199 23.62 1.25 2.67 I
Washington Hosp Ctr. USA 153 28.33 1.49 1.18 I
Univ. Ulsan South Korea 146 23.99 1.27 1.28 I
Boston Sci Corp. USA 136 33.36 1.76 2.44 I
Cleveland Clin Fdn. USA 133 39.02 2.06 1.85 I
Seoul Natl Univ. South Korea 132 13.87 0.73 0.95 III
Brigham & Womens Hosp. USA 129 48.69 2.57 1.91 I
Mayo Clin. USA 124 32.58 1.72 2.30 I
Yonsei Univ. South Korea 119 13.82 0.73 0.75 III
Tech Univ. Munich Germany 112 43.08 2.27 1.93 I
Ctr.Cuore Columbus Italy 104 43.34 2.29 2.09 I
Univ. Hosp Bern Switzerland 104 41.46 2.19 2.81 I
Duke Univ. USA 102 37.61 1.98 1.65 I
Stanford Univ. USA 101 24.95 1.32 2.20 I
Mt Sinai Med Ctr. USA 98 24.31 1.28 2.24 I
Univ. Toronto Canada 79 33.70 1.78 1.76 I
Shanghai Jiao Tong Univ. China 75 8.31 0.44 0.88 III
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the period is divided into 3 parts. Figures 7, 8 and 9
shows the density view of keyword map based on the
co-occurrence matrix by periods. The color of the point
in a map represents the density of the point dependingFigure 6 L-factor vs. Q-factor of top-20 institutions; the size of
circles refers the number of publications.on the number of neighboring items and on the weights
of these items. The color of point with the larger num-
ber of neighboring items of a point and the higher
weights of neighboring items is to be red. Consequently,
the opposite case is to be blue. Also, the font size of the
item’s label depends on the weight of the item which is
determined by the appearance frequency. And the loca-
tion of the words reflects the Euclidean distances bet-
ween all pairs of items [6].
The Period I during first 10 years from 1986 to 1995
is the beginning stage. As shown in Figure 7, the
words such as ‘stent’, ‘restenosis’, ‘biocompatible’ are ap-
peared with a few frequencies. The Period II (1996 ~
2005) could be regarded as a time of differentiation.
Figure 8 shows that the number of keywords are rapidly
increased and diversified as the advances of research on
stent. The remarkable keywords are ‘coronary artery
disease’, ‘drug eluting stent’, ‘thrombosis’, ‘inflammation’,
‘drug-coated stent’, and so on. Period III (2006 ~ 2013)
is called as the time of expansion and stabilization. As
seen in Figure 9, ‘drug eluting stent’ is emerging as a
main topic of stent-related research and keywords such
as ‘paclitaxel’, ‘sirolimus’, ‘drug delivery’, ‘zotarolimus’,
‘everolimus biodegradable polymer’, ‘endothelial func-
tion’ stand out as being representative words. We are
able to know that many efforts are under way to
high
low
Figure 7 Density view of keyword map in Period I (1986 ~ 1995); the red color corresponds the highest density and the blue color
corresponds the lowest density.
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thrombosis. These keywords network analysis results
correspond to the previous reports on development of
stent-related research [7].Conclusions
Since the first stent was implanted in human coronary
arteries by Puel and Sigwart in 1986, the advances of
interventional treatment of coronary artery disease was
remarkably progressed. It was results from the continu-
ous development of the medical kits including stents,
the accumulative experiences of operators and use of
new antiplatelets [8]. Nowadays, stent coated with new
polymeric drugs may have different activities in terms
of affecting endothelium and vascular inflammation.
Polymeric drug coating with NO-donors may decrease
platelet adhesion and coagulation. Stent coated with
polymeric CD34-antibodies may be able to prevent
thrombosis by accelerating endothelial coverage and
may capture circulating endothelial progenitor cells.
Furthermore, development of biodegradable stents
might also be useful way to decrease the incidence of
late thrombosis on the stent. Anti-thrombotic therapy
may be likely to be optimized with the development ofmore newly efficient anti-coagulant and anti-platelet drugs
with a lower risk of bleeding complications [9,10].
The research trends on stent for blood arteries are
reviewed by bibliometric analysis using 7,790 journal
articles of Web of Science database published from
1986 to 2013. We have applied the bibliometric indica-
tors to analyze the journal article data, which contain
simple number of publications for selecting key players,
citation indicators for measuring qualitative research
performance, collaboration indicators for figuring out
the degree of international collaboration and keyword
mapping for identifying the research trends. The stent-
related research has been performed in 71 countries in-
cluding USA, Germany, Italy, etc. The countries at the
forefront published many high-quality journal articles
with strong international collaboration. The top-20 in-
stitutions such as Columbia University, Cardiovascular
Research Foundation, Harvard University, etc. are also
investigated as the core institutions on stent-related re-
search. On the basis of the keyword network maps as
time period, the research trends in a view of topic
changing are finally explored. The topics such as ‘drug
eluting stent’, ‘stent coated with new polymers’ and
‘drug delivery systems’ are prominent lately, which
means lots of efforts are under way to overcome the
high
low
Figure 9 Density view of keyword map in Period III (2006 ~ 2013).
high
low
Figure 8 Density view of keyword map in Period II (1996 ~ 2005).
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bosis and polymeric drug coatings. The future of stent is
expected to be more perspective on developing of innova-
tive ‘biodegradable/bioabsorbable’ polymer and stents.
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